2022 Annual Meeting | C3 - Treatment of Pediatric Multiple Sclerosis in the Current Era

Date Saturday 04/02/22

Time 07:00 AM - 09:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Brenda L. Banwell, MD, FAAN

Topic(s) Multiple Sclerosis, Child Neurology and Developmental Neurology

Learning Objectives The Pediatric Multiple Sclerosis Therapy course will address the following: increase attendee knowledge regarding the approach to the diagnosis of Pediatric MS including considerations of MOG testing, will summarize current literature regarding treatments for acute relapses and for disease modulation and will address the impact of pediatric MS on cognitive function and academics and strategies for rehabilitation.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Advanced

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM PDT	Introduction	Welcome and Introduction Brenda L. Banwell, MD, FAAN
07:00 AM - 09:00 AM PDT	Speaker	walk in slides Brenda L. Banwell, MD, FAAN
07:05 AM - 07:40 AM PDT	Speaker	Diagnosis of Pediatric MS Including Considerations of MOG Testing Brenda L. Banwell, MD, FAAN
07:40 AM - 08:15 AM PDT	Speaker	Current Therapies and the Emerging Treatment Landscape Jennifer Graves, MD, PhD
08:15 AM - 08:50 AM PDT	Speaker	Impact of Pediatric MS on Cognitive Function and Academics and Strategies for Rehabilitation Wendy S. Vargas, MD
08:50 AM - 09:00 AM PDT	Q&A	Questions and Answers Brenda L. Banwell, MD, FAAN, Jennifer Graves, MD, PhD, Wendy S. Vargas, MD

Faculty Disclosures
Brenda L. Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Jennifer Graves, MD, PhD	Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Wendy S. Vargas, MD	Dr. Vargas has received personal compensation for serving as an employee of Sanofi.

��ɫ��

��ɫ��